These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36294874)

  • 1. Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis.
    Leodori G; Pellicano C; Basile V; Colalillo A; Navarini L; Gigante A; Gulli F; Marino M; Basile U; Rosato E
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.
    Matsuda KM; Yoshizaki A; Kuzumi A; Fukasawa T; Ebata S; Miura S; Toyama T; Yoshizaki A; Sumida H; Asano Y; Oba K; Sato S
    Arthritis Res Ther; 2019 May; 21(1):129. PubMed ID: 31138286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.
    Wannarong T; Muangchan C
    Rheumatol Int; 2018 Dec; 38(12):2279-2288. PubMed ID: 30206672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis.
    Chen C; Wang L; Wu J; Lu M; Yang S; Ye W; Guan M; Liang M; Zou H
    Front Pharmacol; 2022; 13():805708. PubMed ID: 35177989
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis: Follow-up of the DESIRES Trial With a Focus on Serum Immunoglobulin Levels.
    Kuzumi A; Ebata S; Fukasawa T; Matsuda KM; Kotani H; Yoshizaki-Ogawa A; Sato S; Yoshizaki A
    JAMA Dermatol; 2023 Apr; 159(4):374-383. PubMed ID: 36790794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis.
    Ledoult E; Launay D; Béhal H; Mouthon L; Pugnet G; Lega JC; Agard C; Allanore Y; Jego P; Fauchais AL; Harlé JR; Berthier S; Aouba A; Mekinian A; Diot E; Truchetet ME; Boulon C; Duhamel A; Hachulla E; Sobanski V;
    Arthritis Res Ther; 2020 Feb; 22(1):30. PubMed ID: 32070422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.
    Bagnato GL; Roberts WN; Fiorenza A; Arcuri C; Certo R; Trimarchi F; Ruggeri RM; Bagnato GF
    Endocrine; 2016 Feb; 51(2):291-7. PubMed ID: 25994300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis.
    Tomčík M; Arima K; Hulejová H; Kuklová M; Filková M; Braun M; Beláček J; Novák M; Bečvář R; Vencovský J; Haluzík M; Gay S; Müller-Ladner U; Distler O; Senolt L
    Cytokine; 2012 May; 58(2):165-8. PubMed ID: 22374311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency ultrasound of skin involvement in systemic sclerosis - a follow-up study.
    Hesselstrand R; Carlestam J; Wildt M; Sandqvist G; Andréasson K
    Arthritis Res Ther; 2015 Nov; 17():329. PubMed ID: 26584645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference.
    Li H; Furst DE; Jin H; Sun C; Wang X; Yang L; He J; Wang Y; Liu A
    Arthritis Res Ther; 2018 Aug; 20(1):181. PubMed ID: 30115105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients.
    Ruaro B; Sulli A; Pizzorni C; Paolino S; Smith V; Alessandri E; Trombetta AC; Alsheyyab J; Cutolo M
    Microvasc Res; 2018 Jan; 115():28-33. PubMed ID: 28834709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How much of skin improvement over time in systemic sclerosis is due to normal ageing? A prospective study with shear-wave elastography.
    Santiago T; Santiago M; Coutinho M; Salvador MJ; Da Silva JAP
    Arthritis Res Ther; 2020 Mar; 22(1):50. PubMed ID: 32188488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis.
    Hasegawa M; Imura-Kumada S; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K
    J Dermatol; 2013 Feb; 40(2):89-93. PubMed ID: 23216308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?
    Lakota K; Wei J; Carns M; Hinchcliff M; Lee J; Whitfield ML; Sodin-Semrl S; Varga J
    Arthritis Res Ther; 2012 May; 14(3):R102. PubMed ID: 22548780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
    Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
    Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker.
    Hesselstrand R; Kassner A; Heinegård D; Saxne T
    Ann Rheum Dis; 2008 Sep; 67(9):1242-8. PubMed ID: 18065498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of serum monocyte-to-high-density lipoprotein cholesterol ratio with digital ulcers and skin fibrosis in patients with systemic sclerosis.
    Kim HB; Kim A; Kim Y; Kim GT; Ahn E; So MW; Sohn DH; Lee SG
    Scand J Rheumatol; 2021 May; 50(3):231-238. PubMed ID: 33243053
    [No Abstract]   [Full Text] [Related]  

  • 18. Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.
    Kuwana M; Allanore Y; Denton CP; Distler JHW; Steen V; Khanna D; Matucci-Cerinic M; Mayes MD; Volkmann ER; Miede C; Gahlemann M; Quaresma M; Alves M; Distler O
    Arthritis Rheumatol; 2022 Mar; 74(3):518-526. PubMed ID: 34514739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status.
    Gheita TA; Sayed S; Azkalany GS; Abaza N; Hammam N; Eissa AH
    Clin Rheumatol; 2018 Mar; 37(3):757-763. PubMed ID: 29076114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durometry for the assessment of skin disease in systemic sclerosis.
    Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
    Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.